116 related articles for article (PubMed ID: 9375024)
1. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
[TBL] [Abstract][Full Text] [Related]
2. Labeling index in squamous cell carcinoma of the larynx.
Balzi M; Ninu BM; Becciolini A; Scubla E; Boanini P; Gallina E; Gallo O; Fini-Storchi O; Bondi R
Head Neck; 1991; 13(4):344-8. PubMed ID: 1869437
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
[TBL] [Abstract][Full Text] [Related]
4. Colonic cell proliferation in normal mucosa of patients with colon cancer.
Becciolini A; Balzi M; Faraoni P; Tisti E; Zappoli Thyrion G; Giachè V; Bandettini L; Potten CS
Acta Oncol; 1998; 37(1):65-71. PubMed ID: 9572656
[TBL] [Abstract][Full Text] [Related]
5. In vitro thymidine labelling of human pulmonary neoplasms.
Kerr KM; Robertson AM; Lamb D
Br J Cancer; 1983 Feb; 47(2):245-52. PubMed ID: 6824569
[TBL] [Abstract][Full Text] [Related]
6. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
[TBL] [Abstract][Full Text] [Related]
7. In vitro thymidine labelling index in primary operable breast cancer.
Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity in normal colon mucosa and tumor tissue: clinical implications.
Balzi M; Becciolini A; Mauri P; Larosa V; Bechi P
In Vivo; 1993; 7(6B):635-7. PubMed ID: 8193286
[TBL] [Abstract][Full Text] [Related]
9. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
Meyer JS; Wittliff JL
Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
[TBL] [Abstract][Full Text] [Related]
10. Kinetic pattern of human urinary transitional cell carcinoma.
Lavezzi AM; Costa A; Milesi M; Matturri L
Basic Appl Histochem; 1986; 30(2):239-42. PubMed ID: 3741320
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
[TBL] [Abstract][Full Text] [Related]
12. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
[TBL] [Abstract][Full Text] [Related]
13. Thymidine labeling index: prognostic role in breast cancer.
Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.
Maurer-Schultze B; Bassukas ID; Böswald M; Harasim M
J Cancer Res Clin Oncol; 1992; 118(4):255-68. PubMed ID: 1577846
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination.
Silvestrini R
Cell Prolif; 1991 Sep; 24(5):437-45. PubMed ID: 1932355
[TBL] [Abstract][Full Text] [Related]
16. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
Bleiberg H; Morret M; Galand P
Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
[TBL] [Abstract][Full Text] [Related]
17. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers.
Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R
Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875
[TBL] [Abstract][Full Text] [Related]
18. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
Kamel OW; Franklin WA; Ringus JC; Meyer JS
Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
[TBL] [Abstract][Full Text] [Related]
19. Amitotic cell divisions and tumour growth: an alternative model for cell kinetic compartments in solid tumours.
Bhattathiri VN
Oral Oncol; 2001 Apr; 37(3):288-95. PubMed ID: 11287284
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
Barbieri F; Parodi G; Massa T; Cagnoli M; Barbi G; Imperiale A; Alama A
Anticancer Res; 1994; 14(5A):1973-7. PubMed ID: 7847836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
